Isolated trisomy 11 in patients with acute myeloid leukemia – Is the prognosis not as grim as previously thought?

類似資料

• Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia
  著者:: Patel, Kishan K., 等
  出版事項: (2021)
• Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: A single center experience
  著者:: Bewersdorf, Jan Philipp, 等
  出版事項: (2020)
• Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
  著者:: Bewersdorf, Jan Philipp, 等
  出版事項: (2019)
• Temporal patterns and predictors of receiving no active therapy among older patients with acute myeloid leukemia in the United States: A population level analysis
  著者:: Zeidan, Amer M., 等
  出版事項: (2019)
• Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia
  著者:: Bewersdorf, Jan Philipp, 等
  出版事項: (2021)